Lupin Limited has informed the Exchange regarding a press release dated November 23, 2023, titled "Lupin Receives Tentative Approval from U.S. FDA for Canagliflozin Tablets".
Press Release Nov 23 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Lupin
- Press Release Nov 21 2023
- Press Release Nov 17 2023
- Press Release Nov 10 2023
- Press Release Nov 08 2023
- Press Release Nov 07 2023
Later from Lupin
- Press Release Dec 01 2023
- Lupin Limited Press Release Dec 06 2023
- Press Release Dec 14 2023
- Press Release Dec 15 2023
- Press Release (Revised) Dec 15 2023
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin